Pharmaceutical Commerce

MARCH 29, 2023

Why automation-enabling tech—such as NLP and ML—can help improve medicine effectiveness.

52

52

European Pharmaceutical Review

MARCH 27, 2023

Adults with treatment-resistant major depressive disorder (TRD) treated with SPRAVATO ® ▼ (esketamine nasal spray [NS]) achieved significantly higher remission rates compared to those given quetiapine extended-release (XR), long-term Phase III study data has shown. The results from Janssen’s ESCAPE-TRD Phase IIIb trial presented at the European Congress of Psychiatry (EPA) 2023 indicated that esketamine NS achieved significantly higher remission rates from Week 6 and response rates as early as D

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies 103

Drug Topics

MARCH 30, 2023

The suit alleges that Express Scripts, Prime and Prime customer Humana Pharmacy Solutions are able to share drug pricing and rebate information to increase prices for insulins, biologics and cancer drugs.

469

469

PhRMA

MARCH 29, 2023

The Patient Experience Survey (PES) series continues to reveal how health insurance is not working as it should for too many Americans — especially vulnerable groups. This series – including surveys of 5,000 Americans conducted with Ipsos, a leading research company in the United States — documents a consistent trend in reports of insurer- and middlemen-imposed practices that can keep patients from the medicines and treatments that they need.

Insurance 321

Insurance Documentation 321

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

MARCH 29, 2023

Psilera founder’s “third eye” approach to psychedelics ushers them into the therapeutic realm.

264

264

STAT

MARCH 30, 2023

New evidence of the spillover of the avian flu virus, known as H5N1, to some mammals is again raising alarm bells, though for experts familiar with the virus, “ none of them ever stopped worrying about H5N1.” The recent death of a Cambodian girl from bird flu is a reminder that much is at stake. If H5N1 were to cross over to humans and ignite another pandemic, could the United States do it all over again?

Vaccines 145

Vaccines FDA 145

PhRMA

MARCH 28, 2023

It’s that time of year again when the president releases his budget and questions arise about the solvency of the Medicare trust fund and Medicare spending more generally. Too often, critics point to spending on Medicare Part B medicines as a key driver of Medicare spending, but the data tells a different story. For example, next month the Medicare Payment Advisory Comission plans to vote on policy proposals that ignore the facts around Medicare Part B, and could harm patient access to both curr

278

278

PharmaVoice

MARCH 29, 2023

Experts weigh in on how companies can design better trials that merge two phases into one.

246

246

STAT

MARCH 29, 2023

The Marburg outbreak in Equatorial Guinea continues to grow, the World Health Organization said Wednesday, as the global health agency stated that it knows of confirmed cases that the country has not yet reported. To date Equatorial Guinea has acknowledged nine laboratory-confirmed cases, seven of whom have died. In addition, 20 other people with links to the confirmed cases died without being tested; they are considered probable cases.

145

145

Drug Topics

MARCH 27, 2023

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Immunization 469

Immunization FDA 469

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PhRMA

MARCH 28, 2023

Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and almost 80% have two or more. Chronic diseases can often limit an older adult’s ability to work, perform daily activities, cause them to lose their independence and lead to the need for long-term care.

278

278

PharmaVoice

MARCH 28, 2023

The Supreme Court will now decide whether Amgen can protect Repatha as a whole class of drugs or whether Sanofi’s rival product Praluent can retain a place in the market.

246

246

Fierce Healthcare

MARCH 31, 2023

CMS to raise Medicare Advantage pay rates by 3.

135

135

Drug Topics

MARCH 26, 2023

Are pharmacists obligated to correct medical misinformation they encounter online?

468

468

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PhRMA

MARCH 30, 2023

At the request of the U.S. Trade Representative, the U.S. International Trade Commission (USITC) is conducting an investigation and will issue an accompanying report concerning the TRIPS Agreement and a variety of issues related to COVID-19 diagnostics and therapeutics. According to USTR, the USITC report will inform future discussions within the United States and at the World Trade Organization (WTO) concerning potential TRIPS waiver expansion.

Vaccines 264

Vaccines 264

PharmaVoice

MARCH 30, 2023

Phages, bacteria’s natural predator, could help combat the growing threat of superbugs. But can these therapies rise above antibiotic market woes?

147

147

STAT

MARCH 28, 2023

A panel of experts that advises the World Health Organization on vaccine use suggested Tuesday that countries no longer need to consider offering additional Covid-19 boosters to people at medium or low risk of becoming seriously ill if they contract the SARS-CoV-2 virus. The Strategic Advisory Group of Experts on Immunization — which is known as the SAGE — said some countries may continue to offer boosters to people at medium and low risk, but those decisions should be made ba

Vaccines 134

Vaccines Immunization 134

Drug Topics

MARCH 28, 2023

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

FDA 468

FDA 468

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PhRMA

MARCH 27, 2023

It’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of the patient’s lung. A dramatic, and not all that common, clinical finding. The patient in front of me already had a fever and was breathing quickly, in need of extra oxygen support.

Vaccines 264

Vaccines 264

PharmaVoice

MARCH 28, 2023

Ahead of turbulent market conditions, EY analyst Arda Ural encourages companies to rethink their sales strategy.

147

147

STAT

MARCH 28, 2023

In the doctor’s offices of the future, artificial intelligence will be a fly on the wall, listening in and logging the sensitive conversations that happen every day between patients and their doctors. Gone will be the distracted doctor hunched over a keyboard, tapping, clicking, constantly playing catch-up with hours of extra work. That’s the vision pitched by a spate of new startups and major tech companies like Microsoft, which one year ago spent over $19 billion to acquire Nuanc

Documentation 133

Documentation Communication Hospitals 133

Drug Topics

MARCH 29, 2023

Pharmacists can provide support and guidance to patients during their month of fasting.

467

467

PhRMA

MARCH 30, 2023

Between Congress, the Medicare Payment Advisory Commission (MedPAC) and the Center for Medicare & Medicaid Innovation (CMMI), there have been a number of policy proposals of late that would change reimbursement for medicines covered by Medicare Part B, some of which may harm patient access to important treatments. As we debate these proposals, it’s important to levelset on how reimbursement works in the program today.

263

263

Fierce Healthcare

MARCH 30, 2023

Uber Health rolls out same-day prescription delivery with plans to ship healthy food, OTC meds hlandi Thu, 03/30/2023 - 12:54

133

133

STAT

MARCH 29, 2023

A growing shortage of monkeys used for early-stage pharmaceutical research is causing concern that many companies will soon face costly delays starting clinical trials — leading to a slowdown in drug development. In recent weeks, the U.S Fish & Wildlife Service began denying company requests to import long-tailed macaques from Cambodia in the wake of a federal investigation into a smuggling ring.

132

132

Drug Topics

MARCH 29, 2023

Though unlikely to pass this year, opponents say the proposal is nonetheless amplifying the spread of false claims and sowing distrust of medical professionals.

Vaccines 465

Vaccines 465

PharmaVoice

MARCH 31, 2023

The major challenges pharma leaders would solve with a quick flick of an imaginary wand.

130

130

Fierce Healthcare

MARCH 30, 2023

Capital Rx exec to senators: Here's how to fix the PBM industry fdiamond Thu, 03/30/2023 - 15:36

129

129

STAT

MARCH 29, 2023

Hidden in this year’s federal spending bill, among major changes to Medicare payments to doctors and post-pandemic Medicaid , lies a little-noticed change with big implications: a mandate to protect medical devices connected to the internet from hacks or ransomware attacks. The law, which goes into effect Wednesday, explicitly states that companies cannot sell their connected medical devices without first showing the Food and Drug Administration a solid cybersecurity plan.

FDA 131

FDA 131

Drug Topics

MARCH 31, 2023

In the world of medication, packaging can make all the difference. Sead Ferhatovic from Jones Healthcare Group joins Drug Topics to talk about blister packs, automation in prescription packaging, and more.

Packaging 462

Packaging 462

PharmaVoice

MARCH 30, 2023

Biomarkers are the hidden talent behind precision medicine, and finding them doesn't have to always come from a blood test — digital pioneers are finding another way.

130

130

Fierce Healthcare

MARCH 29, 2023

UnitedHealthcare to begin reducing prior authorizations this summer pminemyer Wed, 03/29/2023 - 17:02

128

128

European Pharmaceutical Review

MARCH 27, 2023

A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 percent between 2022 and 2027. According to the data, the market is forecasted to increase by $2,487.91 million. The research includes historic market data from 2017 to 2021, using 2022 as the base year. It covers various testing methods such as growth-based, nucleic-acid-based and viability-based.

Compounding 115

Compounding Vaccines 115